Tesla CEO Elon Musk on July 2 tweeted about the company's plans to aid German drugmaker CureVac in its efforts to produce a COVID-19 vaccine.

Six drugs approved by the FDA since June 12:

The Pharmaceutical Research and Manufacturers of America, the drug industry's top lobbying group, has sued Minnesota over a law set to take effect July 1 that was designed to prevent people from rationing their insulin, STAT reported. 

Novartis has agreed to pay $678 million to settle a lawsuit claiming it bribed physicians to boost prescriptions of its drugs, the U.S. Justice Department announced July 1. 

Coeur d'Alene, Idaho-based Interlake Pharmacy is joining Kootenai Health, a health system based in the same city that serves much of the state's northern population.

Ten hospitals and health systems posted job listings seeking pharmacy leaders in the last week.

Two U.S. senators introduced a bill June 30 that would establish a study to analyze the country's dependence on foreign companies in the pharmaceutical supply chain.

The FDA recently delivered guidance for vaccine developers on how effective a COVID-19 vaccine will have to be to win full regulatory approval.

Pfizer and BioNTech released the first clinical data on their experimental COVID-19 vaccine July 1, showing it created an immune response in healthy patients, STAT reported. 

Walgreens is testing a new type of store that cuts down on square footage and emphasizes the pharmacy. Internally, the pilot project is dubbed "Cooper," according to CNBC. 

Below are the 10 top pharmacy stories published by Becker's Hospital Review in June, beginning with the most popular:

Gilead's choice to make less money off its COVID-19 drug remdesivir to ensure more equitable access is a move that could lead to messy consequences in the pharmaceutical industry, according to STAT.

CVS Health reportedly is launching a group purchasing organization for its pharmacy benefit manager business, according to a Nephron Research report cited by Drug Channels.

Humana has entered into a collaboration with Walmart and Quest Diagnostics to help expand COVID-19 testing for its members. 

The FDA will discuss its guidance on vaccine approval during a June 30 appearance before a Senate committee, according to The Wall Street Journal.

HHS said June 29 that it has secured more than 500,000 treatment courses of remdesivir through September that U.S. hospitals can purchase.

Between January 20 and June 20, drugmakers across the globe raised prices on 245 drugs, including 61 that were used to treat symptoms of the novel coronavirus, according to a new report by Patients for Affordable Drugs.

A federal intelligence report found that the U.S. is likely to see a worsening shortage of generic drugs if another round of shutdowns occurs due to the COVID-19 pandemic, according to ABC News. 

Pfizer filed a lawsuit June 26 accusing HHS of blocking it from providing financial aid to Medicare beneficiaries for its two heart disease drugs.

Two patients in Audentes Therapeutics' study testing a gene therapy for a rare muscle disorder called X-linked myotubular myopathy have died, according to STAT.